Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Siemens Healthineers forecasts slower 2027 growth as China weakness persists

By Reuters News

By Kira Britten and Paolo Laudani

Nov 5 - German medical technology company Siemens Healthineers SHLG.DE forecast slower-than-expected growth in fiscal 2027 on Thursday after weakness in China continued to weigh on its diagnostics business.

The company expects fiscal 2027 comparable revenue growth of 4%-5%, below analyst expectations of 5.5%.

It forecast adjusted earnings per share of 2.20 euros to 2.40 euros, compared with analyst expectations of 2.37 euros and fiscal 2026 adjusted EPS of 2.42 euros.

  • Fourth-quarter adjusted EBIT fell 2.0% to 1.077 billion euros from 1.098 billion euros a year earlier

  • Fourth-quarter revenue rose 7.3% to 6.784 billion euros from 6.322 billion euros a year earlier

  • Fourth-quarter diagnostics revenue fell 4.2% on a comparable basis to 1.067 billion euros

  • Weakness in China remained a challenge, with diagnostics revenue in the region hurt by structural changes in the market environment

  • China accounts for about 10% of group revenue and is Siemens Healthineers' second-largest market after the US

  • The German company will change its name to Healthineers as part of its planned spin-off from Siemens, which shareholders are due to vote on in February 2027

  • Shares were seen down about 5% in pre-market trading

https://www.reuters.com/graphics/SIEMENSHEALTH-RESULTS/xmvjwmynbpr/chart.png

($1 = 0.8880 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.